晚期细胞疗法的信息价值分析：一项系统综述

Value of information analyses for advanced cell therapies: a systematic review.

信息价值分析将有助于决策者、分析人员和制造商了解，为减少先进细胞疗法上市时的决策不确定性，长期数据收集是否值得。当前估计表明，进一步研究的价值可能较低。如果未来先进细胞疗法的定价使其相应的增量成本效果比与相关成本效果阈值一致，并且其适应症针对更大的受益人群，那么收集额外数据的价值可能会增加。

病例报告：转移性黑色素瘤合并慢性淋巴细胞白血病/小淋巴细胞淋巴瘤患者对 TIL（肿瘤浸润淋巴细胞）治疗的持久缓解

Case Report: Durable response to tumor-infiltrating lymphocyte therapy in a patient with metastatic melanoma and chronic lymphocytic leukemia/small ly

基因工程改造 T 细胞与 TIL（肿瘤浸润淋巴细胞）疗法

Genetically engineered T cell and tumour-infiltrating lymphocyte therapies.

通过高分辨率质谱和新算法预测快速直接发现功能性肿瘤特异性新抗原

Rapid and direct discovery of functional tumor specific neoantigens by high resolution mass spectrometry and novel algorithm prediction.

CAR-T 细胞与过继性 T 细胞疗法在淋巴及实体器官恶性肿瘤中的综述

A Review of CAR T Cells and Adoptive T-Cell Therapies in Lymphoid and Solid Organ Malignancies.

替米考星在大鼠中的心脏毒性探究及红景天提取物的保护作用：细胞因子、抗氧化、凋亡与抗纤维化通路的潜在作用

Exploration of Tilmicosin Cardiotoxicity in Rats and the Protecting Role of the Rhodiola rosea Extract: Potential Roles of Cytokines, Antioxidant, Apo

与肿瘤免疫治疗和生物制剂相关的心脏毒性

Cardiac Toxicity Associated with Cancer Immunotherapy and Biological Drugs.